Schubert & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$421K Buy
351
+48
+16% +$49K 0.29% 47
2026
Q1
$279K Sell
303
-33
-10% -$33.5K 0.23% 59
2025
Q4
$361K Buy
+336
New +$321K 0.29% 53
2025
Q2
Sell
-256
Closed -$211K 77
2025
Q1
$211K Buy
+256
New +$213K 0.14% 62
2023
Q2
Sell
-128
Closed -$44K 858
2023
Q1
$44K Sell
128
-32
-20% -$10.8K 0.04% 77
2022
Q4
$58.5K Buy
160
+16
+11% +$5.67K 0.05% 61
2022
Q3
$47K Buy
144
+28
+24% +$8.87K 0.04% 67
2022
Q2
$38K Buy
116
+62
+115% +$18.6K 0.04% 79
2022
Q1
$15K Buy
54
+9
+20% +$2.32K 0.02% 93
2021
Q4
$12K Buy
+45
New +$11.4K 0.01% 88

Other funds holding LLY

Schubert & Co's LLY Position: Q2 2026 in Review

Schubert & Co increased its Eli Lilly (LLY) stake by 16% in Q2 2026, buying an estimated $49K and bringing the position to 351 shares worth $421K. The position accounts for 0.29% of the portfolio, ranked #47.

Schubert & Co first reported a position in LLY in Q4 2021 and has held it in 10 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Schubert & Co held 351 shares of Eli Lilly worth $421K as of Q2 2026.
  • Schubert & Co bought 48 Eli Lilly shares in Q2 2026, an estimated $49K.
  • Eli Lilly made up 0.29% of Schubert & Co's portfolio in Q2 2026, its #47 holding.
  • Schubert & Co first reported a position in Eli Lilly in Q4 2021 and has held it in 10 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Schubert & Co's 13F filing for Q2 2026, filed 30 Jul 2026.